{"id":908505,"date":"2025-11-11T10:00:07","date_gmt":"2025-11-11T15:00:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\/"},"modified":"2025-11-11T10:00:07","modified_gmt":"2025-11-11T15:00:07","slug":"shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\/","title":{"rendered":"Shareholders who lost money in shares of DexCom, Inc.  (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p class=\"prntac\">\n        <b>Lead Plaintiff Deadline is <span class=\"xn-chron\">December 26, 2025<\/span><\/b>\n      <\/p>\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">NEW YORK<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Nov. 11, 2025<\/span><\/span> \/PRNewswire\/ &#8212; <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4554395-2&amp;h=3559203889&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Fdexcom-inc-nasdaq-dxcm%2F&amp;a=Wolf+Haldenstein+Adler+Freeman+%26+Herz+LLP\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-person\">Wolf Haldenstein Adler Freeman<\/span> &amp; Herz LLP<\/a>\u00a0reminds \u00a0investors that a federal securities class action lawsuit has been filed against <b>DexCom, Inc.<\/b> (&#8220;DexCom&#8221; or the &#8220;Company&#8221;) (NASDAQ: DXCM) and certain of its officers for <span>alleged<\/span> violations of federal securities laws.\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\" title=\"(PRNewsfoto\/Wolf Haldenstein Adler Freeman )\" alt=\"(PRNewsfoto\/Wolf Haldenstein Adler Freeman )\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p class=\"prntac\">\n        <b><br \/>\n          <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4554395-2&amp;h=3975647380&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Fdexcom-inc-nasdaq-dxcm%2F&amp;a=PLEASE+CLICK+HERE+TO+JOIN+THE+CASE+AND+SUBMIT+CONTACT+INFORMATION\" target=\"_blank\" rel=\"nofollow\">PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION<\/a><br \/>\n        <\/b>\n      <\/p>\n<p>\n        <b>Class Period:<\/b>\u00a0July 26, 2024 \u2013 <span class=\"xn-chron\">September 17, 2025<\/span> (inclusive)<\/p>\n<p>The complaint <span>alleges<\/span> that throughout the Class Period, Defendants made materially false and misleading statements and failed to disclose that:<\/p>\n<ol type=\"1\">\n<li>DexCom made material design changes to its G6 and G7 continuous glucose monitoring devices without authorization from the U.S. Food and Drug Administration (FDA)<\/li>\n<li>These unauthorized changes made the devices less reliable and posed health risks to users;<\/li>\n<li>The Company overstated the reliability, accuracy and functionality of the G7 device;<\/li>\n<li>DexCom downplayed the scope and severity of these issues; and<\/li>\n<li>The Company faced increased risks of regulatory scrutiny, enforcement action and financial harm.<\/li>\n<\/ol>\n<p>\n        <b>Key Events:<\/b>\n      <\/p>\n<ul type=\"disc\">\n<li>\n          <span class=\"xn-chron\">March 10, 2025<\/span> \u2013 FDA Warning Letter:<br \/>The FDA issued a Warning Letter stating that\u00a0DexCom had <i>&#8220;adulterated&#8221;<\/i> its G6 and G7 sensors by modifying them without prior approval, resulting in larger inaccuracies and increased health risks for users. \u00a0<b>Stock dropped <span class=\"xn-money\">$7.12<\/span> (\u22129.15%) to <span class=\"xn-money\">$70.72<\/span><\/b>.<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>March 25\u201326, 2025 \u2013 Public Disclosure:<br \/>The FDA published the Warning Letter on its website, further confirming the product issues<b>. Stock fell another <span class=\"xn-money\">$3.19<\/span> (\u22124.24%) to <span class=\"xn-money\">$72.13<\/span>.<\/b><\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <span class=\"xn-chron\">September 8, 2025<\/span> \u2013 Oppenheimer Downgrade:<br \/>Oppenheimer downgraded DexCom to &#8220;perform&#8221; from &#8220;outperform&#8221;, citing rising patient concerns over G7 sensor accuracy issues, failed insertions, and abrupt stoppages. Stock <b>declined <span class=\"xn-money\">$2.51<\/span> (\u22123.12%) to <span class=\"xn-money\">$78.00<\/span>.<\/b><\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <span class=\"xn-chron\">September 18, 2025<\/span> \u2013 Hunterbrook Report:<br \/>Hunterbrook Research published a report titled <i>&#8220;DexCom&#8217;s Fatal Flaws,&#8221;<\/i> revealing through FDA records and interviews that G7 devices had caused hospitalizations and deaths due to inaccurate readings. The report accused DexCom of cutting<b> corners to <\/b>protect margins. <b>Stock plunged <span class=\"xn-money\">$8.99<\/span> (\u221211.76%) over two sessions to <span class=\"xn-money\">$67.45<\/span>.<\/b><\/li>\n<\/ul>\n<p>\n        <b>What Are The Next Steps:<\/b>\n      <\/p>\n<p>Investors who purchased or otherwise acquired DexCom securities during the Class Period may move the Court no later than <b><span class=\"xn-chron\">December 26, 2025<\/span><\/b>, to be appointed lead plaintiff.<\/p>\n<p class=\"prntac\">\n        <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4554395-2&amp;h=938603515&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Fdexcom-inc-nasdaq-dxcm%2F&amp;a=Why%C2%A0Wolf+Haldenstein+Adler+Freeman+%26+Herz+LLP%3F\" target=\"_blank\" rel=\"nofollow\"><br \/>\n          <b>Why<\/b>\u00a0<b><span class=\"xn-person\">Wolf Haldenstein Adler Freeman<\/span> &amp; Herz LLP?<\/b><\/a><br \/>\n        <b>:<\/b>\n      <\/p>\n<p>This illustrious <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4554395-2&amp;h=165048880&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Fdexcom-inc-nasdaq-dxcm%2F&amp;a=firm\" target=\"_blank\" rel=\"nofollow\">firm<\/a>, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements.\u00a0<a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4554395-2&amp;h=3854806062&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Fdexcom-inc-nasdaq-dxcm%2F&amp;a=The+law+firm%C2%A0\" target=\"_blank\" rel=\"nofollow\">The law firm\u00a0<\/a>brings to the fore over 125 years of legal expertise in securities litigation and has a proven track record of protecting the rights of investors.<\/p>\n<p>We encourage all investors who have been affected or have information that will assist in our investigation, to contact\u00a0<a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4554395-2&amp;h=3559203889&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Fdexcom-inc-nasdaq-dxcm%2F&amp;a=Wolf+Haldenstein+Adler+Freeman+%26+Herz+LLP\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-person\">Wolf Haldenstein Adler Freeman<\/span> &amp; Herz LLP<\/a>.<\/p>\n<p>\n        <b>Contact:<\/b>\n      <\/p>\n<ul type=\"disc\">\n<li>\n          <b>Phone:<\/b>\u00a0(800) 575-0735 or (212) 545-4774<\/li>\n<li>\n          <b>Email:\u00a0<\/b><br \/>\n          <a href=\"mailto:classmember@whafh.com\" target=\"_blank\" rel=\"nofollow\">classmember@whafh.com<\/a>\n        <\/li>\n<li>\n          <b>Contact Person:<\/b>\u00a0<a href=\"mailto:gstone@whafh.com\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-person\">Gregory Stone<\/span>, Director of Case and Financial Analysis<\/a><\/li>\n<\/ul>\n<p>\n        <b>Firm Website:<\/b><br \/>\n        <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4554395-2&amp;h=2431647372&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Fdexcom-inc-nasdaq-dxcm%2F&amp;a=%C2%A0Wolf+Haldenstein+Adler+Freeman+%26+Herz+LLP\" target=\"_blank\" rel=\"nofollow\">\u00a0Wolf Haldenstein Adler Freeman &amp; Herz LLP<\/a>\n      <\/p>\n<p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=NY20472&amp;sd=2025-11-11\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/shareholders-who-lost-money-in-shares-of-dexcom-inc--nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-302611309.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/shareholders-who-lost-money-in-shares-of-dexcom-inc&#8211;nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-302611309.html<\/a><\/p>\n<p>SOURCE  <span class=\"xn-person\">Wolf Haldenstein Adler Freeman<\/span> &amp; Herz LLP<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY20472&amp;Transmission_Id=202511110918PR_NEWS_USPR_____NY20472&amp;DateId=20251111\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire Lead Plaintiff Deadline is December 26, 2025 NEW YORK , Nov. 11, 2025 \/PRNewswire\/ &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP\u00a0reminds \u00a0investors that a federal securities class action lawsuit has been filed against DexCom, Inc. (&#8220;DexCom&#8221; or the &#8220;Company&#8221;) (NASDAQ: DXCM) and certain of its officers for alleged violations of federal securities laws.\u00a0 PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION Class Period:\u00a0July 26, 2024 \u2013 September 17, 2025 (inclusive) The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and failed to disclose that: DexCom made material design changes to its G6 and G7 continuous glucose monitoring devices without authorization from the U.S. Food and Drug Administration (FDA) &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Shareholders who lost money in shares of DexCom, Inc.  (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-908505","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Lead Plaintiff Deadline is December 26, 2025 NEW YORK , Nov. 11, 2025 \/PRNewswire\/ &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP\u00a0reminds \u00a0investors that a federal securities class action lawsuit has been filed against DexCom, Inc. (&#8220;DexCom&#8221; or the &#8220;Company&#8221;) (NASDAQ: DXCM) and certain of its officers for alleged violations of federal securities laws.\u00a0 PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION Class Period:\u00a0July 26, 2024 \u2013 September 17, 2025 (inclusive) The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and failed to disclose that: DexCom made material design changes to its G6 and G7 continuous glucose monitoring devices without authorization from the U.S. Food and Drug Administration (FDA) &hellip; Continue reading &quot;Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-11T15:00:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately\",\"datePublished\":\"2025-11-11T15:00:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\\\/\"},\"wordCount\":495,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064977\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\\\/\",\"name\":\"Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064977\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\",\"datePublished\":\"2025-11-11T15:00:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064977\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064977\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\/","og_locale":"en_US","og_type":"article","og_title":"Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately - Market Newsdesk","og_description":"PR Newswire Lead Plaintiff Deadline is December 26, 2025 NEW YORK , Nov. 11, 2025 \/PRNewswire\/ &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP\u00a0reminds \u00a0investors that a federal securities class action lawsuit has been filed against DexCom, Inc. (&#8220;DexCom&#8221; or the &#8220;Company&#8221;) (NASDAQ: DXCM) and certain of its officers for alleged violations of federal securities laws.\u00a0 PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION Class Period:\u00a0July 26, 2024 \u2013 September 17, 2025 (inclusive) The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and failed to disclose that: DexCom made material design changes to its G6 and G7 continuous glucose monitoring devices without authorization from the U.S. Food and Drug Administration (FDA) &hellip; Continue reading \"Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-11T15:00:07+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately","datePublished":"2025-11-11T15:00:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\/"},"wordCount":495,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\/","name":"Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","datePublished":"2025-11-11T15:00:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/908505","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=908505"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/908505\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=908505"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=908505"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=908505"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}